Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Haller, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haller, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 701-703
© 2002 European Renal Association-European Dialysis and Transplant Association

Editorial Comments

Percutaneous coronary interventions in patients with renal failure: overcoming in-stent restenosis?

Christlieb Haller

Department of Internal Medicine, Division of Cardiology, University of Heidelberg, Heidelberg, Germany

Keywords: end-stage renal disease

Introduction

Patients with end-stage renal disease (ESRD) have a 20- to 40-fold higher cardiovascular mortality than patients without renal disease [1]; 52% of dialysis patients surviving an acute myocardial infarction die from a cardiac cause within the following 2 years [2]. This very unfavourable prognosis of ischaemic heart disease in dialysis patients is not only due to the severity of coronary artery disease, but may also reflect the underutilization of modern treatment measures for acute myocardical infarction [1,2].

One of the reasons for the underutilization of coronary revascularization procedures in the ESRD population may be the perception that patients with chronic renal failure (CRF) benefit less from coronary angiography, as they often have diffusely calcified coronary artery disease, which is neither suited to percutaneous nor to surgical revascularization. Nevertheless, several studies have shown that surgical revascularization has a . . . [Full Text of this Article]

Stenting

Inhibition of platelet function

Management of restenosis

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?